Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
C. Difficile Colitis
100%
Treatment Failure
65%
Vancomycin-resistant Enterococcus Faecium (VREfm)
65%
High Risk
43%
Clostridioides Difficile
37%
Community Hospital
35%
Hospitalized Patients
32%
Recommended Strategies
32%
Septic Arthritis
32%
Antibiotic-associated Hemorrhagic Colitis
32%
Randomized Clinical Trial
32%
Convalescent Plasma
32%
New Threats
32%
Invasive Pneumococcal Disease
32%
Vengeance
32%
Ocular Tuberculosis
32%
Mucormycosis
32%
Missed Diagnosis
32%
COVID-19
32%
Incessant Tachycardia
32%
Identification of High-risk Patients
32%
Abdominal
32%
Tuberculosis Surveillance
32%
Myocarditis
32%
Necrotizing Fasciitis
32%
Tuberculosis Treatment Outcomes
32%
Serological Tests
32%
Treatment Response
32%
Fungal Coinfection
32%
Hospital Workers
32%
Clinical Relapse
32%
Lyme Disease
32%
Ocular Manifestations
32%
Renal Manifestations
32%
Prospective Evaluation
32%
Prognostic Criteria
32%
Polymicrobial
32%
Influenza
32%
Antibiotics
32%
Adjusted Odds Ratio
23%
Number of Employees
21%
Low Risk
21%
C. Kroppenstedtii
21%
Mycobacterium Tuberculosis (M. tb)
21%
Patient Care
21%
Conversion Rate
21%
Amoxicillin-clavulanate
21%
Tuberculin Skin Test
21%
Systemic Antibiotic Treatment
16%
Underlying Medical Conditions
16%
Medicine and Dentistry
Antibiotic Therapy
70%
Antibiotics
41%
Peritonitis
40%
Acquired Immune Deficiency Syndrome
40%
Central Venous Catheter
32%
Catheter Infection
32%
Clostridium Difficile Infection
32%
Health Care Cost
32%
Pneumococcal Infection
32%
Intensive Care
32%
COVID-19
32%
Vascular Access
32%
Outpatient Care
32%
Septic Arthritis
32%
Treatment Response
32%
Granulomatous Mastitis
32%
Odds Ratio
32%
Breast Abscess
32%
Corynebacterium
32%
Lyme Disease
32%
Vancomycin Resistant Enterococcus
32%
Convalescence
32%
Tuberculosis Treatment
32%
Liver Cirrhosis
32%
Randomized Clinical Trials
32%
Enterococcal Infection
32%
Sepsis
27%
Intensive Care Medicine
22%
Gout
21%
Ocular Tuberculosis
21%
Antifungal Therapy
21%
Paracentesis
21%
Amphotericin
21%
Kidney Function
21%
Diseases
20%
Placebo
19%
Infection
19%
Pathogen
19%
Serum Albumin
16%
Student T Test
16%
Fisher Exact Test
16%
Pneumococcus
10%
Incision
10%
Leukocytosis
10%
Heart Failure with Reduced Ejection Fraction
10%
Blood Culture
10%
Maturity Onset Diabetes of the Young
10%
Debridement
10%
Kidney Tuberculosis
10%
Itraconazole
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridium Difficile Infection
65%
Antimicrobial Agent
54%
Antibiotics
48%
Heart Ventricle Tachycardia
32%
Randomized Clinical Trial
32%
Infectious Agent
32%
Liver Cirrhosis
32%
Necrotizing Fasciitis
32%
Convalescence
32%
Peritonitis
32%
Catheter Infection
32%
Myocarditis
32%
Influenza
32%
Mixed Infection
32%
Hemorrhagic Colitis
32%
Mucormycosis
32%
Candida Glabrata
32%
Serum Albumin
27%
Infection
24%
Clavulanic Acid
21%
Amoxicillin
21%
Antifungal Therapy
21%
Amphotericin
21%
Placebo
19%
Skin Infection
13%
Diseases
13%
Antiinfective Agent
10%
Multiple Organ Failure
10%
Diarrhea
10%
Autoimmune Hepatitis
10%
Itraconazole
10%
Sinusitis
10%
Sepsis
10%
Bloodstream Infection
10%
Penicillinase
10%
Hemodialysis
10%
Bloody Diarrhea
10%
SARS Coronavirus
9%
Metronidazole
8%
Vancomycin
8%
Colitis
8%
Ketoacidosis
6%
Blood Transfusion Reaction
6%
Soft Tissue Infection
6%
Immunocompromised Patient
6%
Saprotroph
6%
Syndrome
6%
Host Factor
6%
Mucorales
6%
Mucor
6%
